Navigation Links
Gen-Probe Announces Webcast of Third Quarter 2007 Earnings Conference Call
Date:10/11/2007

SAN DIEGO, Oct. 11 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will release its third quarter 2007 financial results on Tuesday, October 30, 2007 at approximately 4:00 p.m. Eastern Time (ET). The announcement will be followed by a conference call at 4:30 p.m. ET hosted by Henry L. Nordhoff, chairman, president and chief executive officer, and Herm Rosenman, senior vice president, finance, and chief financial officer.

The conference call will be webcast live and may be accessed on the investment information section of the Company's web site at http://www.gen-probe.com. An archived version of the webcast will be available on the same web site for at least 90 days. A telephone replay also will be available for 24 hours after the call ends. To access the replay, please call 800-947-6450 (U.S.) or 203- 369-3539. (international).

About Gen-Probe

Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has more than 24 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives,
'/>"/>

SOURCE Gen-Probe Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014 ... investing £2.5 million to help it meet the ... goods, healthcare, pharmaceuticals and logistics. Albion joins Shackleton ... ) Over the past 18 months ... its platform, its management team and its operations. ...
(Date:7/25/2014)... July 25, 2014  Depomed, Inc. (NASDAQ: ... quarter fiscal year 2014 financial results after the market ... a conference call beginning at 4:30 pm EDT, 1:30 pm PDT ... the call by dialing 877-317-6789 ( United States ... also be available via a live webcast on the ...
(Date:7/25/2014)... 2014 GrowBLOX Sciences, Inc. (OTCQB: GBLX) is pleased ... ("MOU") with LaurelCo, LLC, an Illinois ... cultivation and dispensary medical marijuana licenses in the state of ... will acquire a 20% equity interest in LaurelCo, LLC in ... growing chambers, as well as all technology related to the ...
Breaking Medicine Technology:OmPrompt Funded for Customer Automation Management Market Expansion 2Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014 2GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 2GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 3
... and LONDON, Nov. 20 Boston Scientific Corporation (NYSE: ... received 510(k) clearance from the U.S. Food and Drug ... WallFlex® Fully Covered Esophageal Stent for the treatment of ... with resectable or non-resectable esophageal cancer. , (Photo: ...
... , HOUSTON, Nov. 20 Cyberonics, Inc. (Nasdaq: CYBX ... and Greg Browne, Chief Financial Officer, will present at the 21st ... December 2, 2009 at 12:00 PM EST. The conference session ... be presented. Piper Jaffray will host a webcast of the ...
Cached Medicine Technology:Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2
(Date:7/28/2014)... the years, many adolescents have been forced to accept ... in their knees. A new PhD study involving 3,000 ... carries on: , "We can see from the study ... of 12 and 19 experience problems with pain in ... knee pain in the front of the knee," says ...
(Date:7/28/2014)... at North Carolina State University is proposing a new ... ability with age, but don,t necessarily show declines in ... be how motivated older adults are to maintain focus ... wanted to explain the difference we see in cognitive ... professor of psychology at NC State and author of ...
(Date:7/28/2014)... July 28, 2014A group of researchers in Taiwan has ... to detect an early complication of diabetes sooner, when ... safe and effective in clinical trials, it may pave ... treatment of this complication, called diabetic autonomic neuropathy, which ... Type 2 diabetes. The condition progressively affects the autonomic ...
(Date:7/28/2014)... of Bradford, UK, have devised a simple blood ... have cancer or not. , The test ... presenting with certain symptoms, saving time and preventing costly ... being carried out. Alternatively, it could be a useful ... a cancer that is currently hard to diagnose. ...
(Date:7/28/2014)... the European project SOPHIE has evaluated the relationship ... inequalities in health in Europe. The results show ... southern Europe) and countries with contradictory policies (Eastern ... women reported poorer health than men. Health inequalities ... women present a 27% higher risk of having ...
Breaking Medicine News(10 mins):Health News:Many people never grow out of their growing pains 2Health News:Motivation explains disconnect between testing and real-life functioning for seniors 2Health News:Wearable device for the early detection of common diabetes-related neurological condition 2Health News:Potential 'universal' blood test for cancer discovered 2Health News:Potential 'universal' blood test for cancer discovered 3Health News:Gender inequalities in health: A matter of policies 2
... Patients believe,that access to their prescription medications ... by unfair reimbursement practices and,policies to their community ... polling company(TM), inc., "Our patients have it ... in their health care," said Stephen Giroux, PD, ...
... Study finds false positives occur 9.2% of the time in ... doctors in the emergency room believe that someone is having ... time, a new study indicates. , Given that minutes matter ... in this setting, that percentage is tolerable, say researchers from ...
... An international team of researchers led by Mayo Clinic have ... a virus to destroy cancer cells that spread from primary ... system. In addition, their study shows that this technology could ... cancer recurrence. , The study appeared in the Dec. 9 ...
... for patients with spinal cord injuries can stimulate ... compensatory changes in the brain, say Canadian researchers. ... function and the ability to walk. , A ... the remarkable benefits of rehabilitation training after a ...
... Island Hospital has received a renewal of a $1.5 million ... examine the driving abilities of elderly drivers. The study is ... elders in their natural driving environments. , Under the ... Alzheimers Disease and Memory Disorders Center at Rhode Island Hospital, ...
... of North America 93rd ... Scientific Assembly and Annual Meeting, NEWPORT NEWS, Va., Dec. ... North America 93rd Scientific,Assembly and Annual Meeting demonstrated the value ... to mammography and,breast ultrasound. The study, performed by Dr. Jean ...
Cached Medicine News:Health News:Study Indicates Strong Consumer Preference to Fix Medicare Part D and Medicaid Flaws Threatening Access to Prescription Drugs 2Health News:Study Indicates Strong Consumer Preference to Fix Medicare Part D and Medicaid Flaws Threatening Access to Prescription Drugs 3Health News:Diagnosis of Heart Attack Can Be Wrong 2Health News:Researchers train the immune system to deliver virus that destroys cancer in lab models 2Health News:Researchers train the immune system to deliver virus that destroys cancer in lab models 3Health News:Intensive training post-spinal cord injury can stimulate repair in brain and spinal cord 2Health News:Breast Cancer Imaging Study Indicates Breast-Specific Gamma Imaging (BSGI) Is a Strong Adjunct Imaging Modality to Mammography and Ultrasound 2Health News:Breast Cancer Imaging Study Indicates Breast-Specific Gamma Imaging (BSGI) Is a Strong Adjunct Imaging Modality to Mammography and Ultrasound 3
... Implant (KGTI) system offers the latest technology ... MPJ. The implant system is anatomically designed ... ,The KGTI is the most advanced reconstructive ... on the market today. The system consists ...
... Ad-Techs Intraoperative Electrodes share ... electrodes. The main difference is ... discs are numbered to assist ... electrodes are designed for use ...
... the Selenia full field digital mammography ... new era in the world of ... innovation combines the latest advances in ... management capabilities to bring you the ...
... The P3000 heralds a new concept in ... binocular infrared optical system developed for the P2000. ... standard in which we have paid particular attention ... Our new system is extremely flexible, allowing ...
Medicine Products: